Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

ClinicalTrials.gov ID: NCT01074294

Public ClinicalTrials.gov record NCT01074294. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adult Attention Deficit/ Hyperactivity Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study tests the effects of an investigational antipsychotic drug (called OPC-34712) in adults with attention deficit hyperactivity disorder (ADHD) when taken with an approved stimulant medication to explore a possible impact on sleep, quality of life and cognitive function.

Study identification

NCT ID
NCT01074294
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
740 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2010
Primary completion
Jun 19, 2011
Completion
Jun 19, 2011
Last update posted
Feb 1, 2023

2010 – 2011

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
35
Facility City State ZIP Site status
Not listed Little Rock Arkansas
Not listed Beverly Hills California
Not listed Irvine California 92612
Not listed Pasadena California
Not listed San Francisco California
Not listed Bradenton Florida
Not listed Jacksonville Florida
Not listed Maitland Florida
Not listed North Miami Florida
Not listed Orlando Florida
Not listed South Miami Florida 33173
Not listed Atlanta Georgia
Not listed Smyrna Georgia
Not listed Indianapolis Indiana
Not listed Overland Park Kansas
Not listed Rochester Hills Michigan
Not listed Saint Charles Missouri
Not listed Cherry Hill New Jersey
Not listed Willingboro New Jersey
Not listed New York New York
Not listed Chapel Hill North Carolina
Not listed Durham North Carolina
Not listed Cincinnati Ohio
Not listed Dayton Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Philadelphia Pennsylvania
Not listed Memphis Tennessee
Not listed Austin Texas
Not listed Houston Texas
Not listed Salt Lake City Utah
Not listed Woodstock Vermont
Not listed Herndon Virginia
Not listed Bellevue Washington
Not listed Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Attention Deficit Hyperactivity Disorder trials

Other public records listing Attention Deficit Hyperactivity Disorder. Sorted by last update posted; newest first. Not a recommendation.

All Attention Deficit Hyperactivity Disorder trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01074294, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2023 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01074294 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →